Kova review
Kova combines clinician-reviewed treatment with an app for tracking progress. Its plan billing can continue independently of refill and review timing.
The verdict
The tracking tools may support a continuing conversation, but they are not the clinician. Pay particular attention to the separation between recurring billing and clinical reviews: delayed intake or an unused refill does not automatically pause the plan.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Kova is a telehealth platform with semaglutide and tirzepatide programs and a companion app for weight, nutrition and symptom tracking.
Who writes the prescription, and what do they see?
Independent providers make prescription and renewal decisions. The terms say the company and app cannot prescribe, recommend or change a dose; patient-entered logs do not by themselves amend a treatment plan.
Patients complete an assessment and access a provider portal. The program describes ongoing check-ins, while its legal terms make patients responsible for completing required refill and review steps.
What happens when the dose goes up?
Clinical eligibility and later prescription decisions remain separate from the subscription. Ask how frequently a clinician reviews tracking entries and what happens to billing when treatment is paused or changed.
What the price includes
The site separates introductory one-month prices from renewal rates and discounted longer plans. The contract also permits fixed-term commitments paid monthly, so monthly billing does not necessarily mean month-to-month cancellation.
What it claims, and what it cites
The public program identifies semaglutide and tirzepatide and discusses compounded versions. Compounded medicines are not FDA-approved; branded-trial averages on the site are not proof of equivalent program outcomes.
Where it holds up, and where it does not
- Strength: App supports symptom and progress tracking
- Strength: Independent clinical decisions stated
- Limitation: Billing can precede refill review
- Limitation: Tracking is not a clinical response guarantee
What the evidence says about this kind of treatment
The assessment above is about Kova. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- Someone who wants app-based tracking and is willing to read the full plan commitment.
- Wrong for
- Someone expecting that skipping a refill automatically stops their charges.
The evidence behind what Kova prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Kova compares
| Seller | Who it suits | Go |
|---|---|---|
| SkinnyRx | Readers choosing tirzepatide, the one line with a published standing rate | See SkinnyRx → |
| ShedRx | Readers willing to telephone a seller and ask which published fee is the real one | See ShedRx → |
| RxSpan MD | Buyers who want the standing rate, the pharmacy and the prescriber named before signing up | See RxSpan MD → |
More GLP-1 telehealth sellers reviews: Onyx Weight LossOpen Water RxOptimized HealthOptions Medical Weight LossOrderlyMedsOria Meds
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Does entering a symptom in the app change my prescription?
- No. Kova’s terms distinguish tracking tools from independent provider decisions. Contact the care team about treatment changes.
- Does a missed refill request pause the plan?
- The terms say it does not, by itself, stop the billing cycle.
Sources for this review
Provider information checked . Terms can change.